These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8097163)

  • 1. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
    Downes RP; Waddington JL
    Eur J Pharmacol; 1993 Mar; 234(1):135-6. PubMed ID: 8097163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.
    Clifford JJ; Tighe O; Croke DT; Kinsella A; Sibley DR; Drago J; Waddington JL
    Neuroscience; 1999; 93(4):1483-9. PubMed ID: 10501473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.
    Undie AS; Weinstock J; Sarau HM; Friedman E
    J Neurochem; 1994 May; 62(5):2045-8. PubMed ID: 7908949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural evidence for cholecystokinin-dopamine D1 receptor interactions in the rat.
    Van Kampen J; Frydryszak H; Stoessl AJ
    Eur J Pharmacol; 1996 Feb; 298(1):7-15. PubMed ID: 8867913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor agonists SKF 83822 vs SKF 83959.
    Fujita S; Kiguchi M; Kobayashi M; Kinsella A; Koshikawa N; Waddington JL
    Eur J Pharmacol; 2010 Apr; 632(1-3):39-44. PubMed ID: 20122923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1989 Feb; 160(3):377-84. PubMed ID: 2565818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
    Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington JL; Koshikawa N
    Eur J Pharmacol; 1999 Feb; 367(2-3):143-9. PubMed ID: 10078986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
    Molloy AG; Waddington JL
    Br J Pharmacol; 1988 Oct; 95(2):335-42. PubMed ID: 2906555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 receptor agonist-induced grooming is blocked by the opioid receptor antagonist naloxone.
    Stoessl AJ
    Eur J Pharmacol; 1994 Jul; 259(3):301-3. PubMed ID: 7982457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats.
    Meyer ME; Shults JM
    Pharmacol Biochem Behav; 1993 Oct; 46(2):269-74. PubMed ID: 7903456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?
    van Kampen J; Stoessl AJ
    Neuropharmacology; 1997; 36(11-12):1679-88. PubMed ID: 9517439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1990 Sep; 186(1):79-86. PubMed ID: 2149339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous desensitization of the human dopamine D1 receptor in Y1 adrenal cells and in a desensitization-resistant Y1 mutant.
    Olson MF; Schimmer BP
    Mol Endocrinol; 1992 Jul; 6(7):1095-102. PubMed ID: 1354841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.